NCT05940766Recrutement en cours
Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients
Résumé
In children and adolescents undergoing chemotherapy for cancer, fever in neutropenia (FN) is the most frequent potentially lethal complication of chemotherapy for cancer. Emergency hospitalization and empirical treatment with i.v. broad-spectrum antibiotics have reduced lethality from \>50% in certain high risk situations to \<1%. Fever without neutropenia is a further complication requiring emergency evaluation and often emergency treatment. Continuous monitoring of fever leads to earlier fever detection compared to the usual discrete fever measurements performed only for clinical reasons. Earlier detection of fever leads to earlier assessment and treatment and thus can reduce the risk of complications. This study primarily aims to assess, in pediatric patients undergoing chemotherapy for cancer, the efficacy of automated fever alerts resulting from continuous fever monitoring (CFM) using a wearable device (WD), measured by the duration of intravenous antibiotics (i.v. AB) given for any cause.
Critères d'inclusion
• Chemotherapy treatment because of any malignancy expected to last ≥2 months at time of recruitment for myelosuppressive therapy, or at least 1 cycle of myeloablative chemotherapy followed by hematopoietic stem cell transplantation • Age ≥1 month and \<18 years at time of recruitment • Written informed consent from patients and/or parents
Critères d'exclusion
• Neonates \<1 months • Local skin disease prohibiting wearing of the WD • Denied written informed consent from patients and/or parents • Inclusion of vulnerable participants mandatory as vital signs and FN episodes differ significantly in children and adults
Contacts
Les coordonnées de l'équipe de l'essai s'affichent sur demande.
Voir la fiche officielle de l'essai- Statut
- Recrutement en cours
- Phase
- Sans phase (N/A)
- Type d'étude
- Interventionnelle
- Pays
- Suisse
- Promoteur
- Insel Gruppe AG, University Hospital Bern(Autre)
- N° de protocole
- Swiss 2024 Fever Monitoring
- Pathologies
- Pediatric Oncology Patients With Risk for Infections
- Interventions
- Autre
Traitements évalués
- Automated fever alerts
Collaborateurs
ETH Zurich
Lieux · 1
- Bern, SuisseChildrens' Clinc Bern, Inselspital BernRecrute dans ce centre
Au total, dans le monde, le seul centre listé au registre recrute.
Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 22 octobre 2026).
Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.
Voir aussi
Autres versions
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.